EGFR and cancer: Epidermal growth factor receptor (EGFR) targeting peptide-modified thiolated gelatin nanoparticles for wild type-p53 gene delivery, delivery efficiency and transfection in pancreatic cells were evaluated so as to repair apoptosis and further trigger cell death in cancer cells.